# Hookworms in Dogs: Cutaneous Larva Migrans and Anemia in Puppies ## Key Takeaways - Hookworm infections in dogs, primarily caused by *Ancylostoma caninum* and *Uncinaria stenocephala*, lead to significant blood loss, resulting in anemia and enteritis, particularly in puppies. Diagnosis in dogs is typically via fecal flotation, with molecular methods like PCR essential for species identification due to emerging drug resistance. - Zoonotic hookworm larvae, mainly *A. braziliense* and *A. caninum*, cause cutaneous larva migrans (CLM) in humans, characterized by intensely pruritic, serpiginous skin tracks acquired through skin contact with contaminated soil or sand. Diagnosis is primarily clinical, based on characteristic lesions and exposure history. - Transmission routes for canine hookworms include ingestion of infective larvae, skin penetration, and transmammary transmission to puppies. Environmental contamination from feces is a critical factor in both canine infection and human CLM exposure. - Multiple anthelmintic drug resistance (MADR) in *Ancylostoma caninum* is a significant and growing concern, with documented resistance to fenbendazole, moxidectin, and pyrantel pamoate. This necessitates strategic deworming protocols, fecal egg count reduction tests (FECRT), and potentially combination therapy. - Treatment for canine hookworms involves anthelmintics such as pyrantel pamoate, fenbendazole, and moxidectin, but resistance necessitates careful selection and monitoring. For human CLM, oral albendazole or ivermectin are the primary treatments, with combination therapy sometimes required for refractory cases. - Prevention strategies include regular veterinary-recommended deworming, prompt and proper disposal of canine feces to minimize environmental contamination, and public awareness campaigns emphasizing hygiene and the zoonotic potential of hookworms. --- Hookworms are among the most significant [intestinal parasites](/knowledge/parasites/pet-parasites/intestinal-parasites-dogs-cats-identification-treatment) affecting dogs worldwide, with a profound impact on both animal and human health. These blood-feeding nematodes are a leading cause of anemia in puppies and a primary source of the distressing skin condition known as cutaneous larva migrans (CLM) in humans. This article provides a comprehensive, source-grounded overview of hookworm biology, the clinical syndromes they cause, the emerging challenge of drug resistance, and evidence-based strategies for diagnosis, treatment, and prevention. For pet owners, the immediate takeaway is that hookworm infections are serious but treatable. Puppies showing signs of pale gums, weakness, or dark, tarry stool require urgent veterinary care. For humans, any itchy, winding, red skin track after contact with soil or sand where dogs may have defecated warrants prompt medical evaluation. This article will guide you through the essential knowledge, but it is educational and is not a substitute for veterinary diagnosis or treatment. ## At a Glance: Hookworm Disease in Dogs and Humans Understanding the dual threat of hookworms is crucial for effective management. The following table summarizes the key differences between the direct infection in dogs and the zoonotic infection in humans. | Feature | Canine Hookworm Disease (e.g., *Ancylostoma caninum*) | Human Cutaneous Larva Migrans (CLM) | | :--- | :--- | :--- | | **Primary Cause** | *A. caninum*, *A. braziliense*, *Uncinaria stenocephala* [1][2] | Zoonotic larvae, primarily *A. braziliense* and *A. caninum* [3] | | **Transmission** | Ingestion of larvae, skin penetration, or transmammary (via mother's milk) | Skin contact with contaminated soil or sand, often barefoot [3][4] | | **Primary Syndrome** | Intestinal parasitism with blood loss, leading to anemia and enteritis [1][5] | Migratory, pruritic, serpiginous skin lesions [3] | | **Key Clinical Signs** | Pale mucous membranes, melena (dark, tarry stool), hematochezia, weight loss, poor growth [1][5] | Intensely itchy, winding red tracks, most commonly on feet and legs [6][4] | | **Diagnosis** | Fecal flotation, fecal egg count, PCR; species identification via molecular methods [7][5] | Clinical diagnosis based on history and lesion appearance [3] | | **Treatment** | Anthelmintics (e.g., pyrantel, fenbendazole, moxidectin); be aware of resistance [5][8] | Oral albendazole or ivermectin, often requiring repeat or combination therapy [6][3] | | **Zoonotic Risk** | Direct risk to humans is primarily CLM; rarely, intestinal infection can occur [9] | N/A (Humans are accidental, dead-end hosts for CLM) | ## The Parasite: Biology and Epidemiology Hookworms are small, thread-like nematodes that attach to the intestinal wall of their host and feed on blood. The most common species affecting dogs include *Ancylostoma caninum*, *Ancylostoma braziliense*, *Ancylostoma ceylanicum*, and *Uncinaria stenocephala* (the northern hookworm) [1][7][2]. The global distribution of these species varies, with *A. caninum* being predominant in warmer regions and *U. stenocephala* more common in temperate climates [1][10][2]. Canine hookworms represent some of the most globally prevalent parasitic nematodes affecting dogs [1]. They pose a significant zoonotic risk, with humans being accidental hosts [1][3]. The life cycle begins when eggs are passed in the feces of an infected [dog](/knowledge/veterinary-medicine/clinical-methods/dog). In warm, moist soil, these eggs hatch into larvae that develop into the infective third stage (L3) [3]. Dogs become infected by ingesting these larvae from a contaminated environment or by larvae penetrating their skin. Puppies can also become infected through the mother's milk (transmammary transmission) [1]. Once inside the host, the larvae migrate to the small intestine, mature into adults, and attach to the intestinal lining to feed on blood. The prevalence of hookworm infection is highly variable and influenced by climate, sanitation, and animal management practices. A systematic review and meta-analysis in Ecuador estimated a pooled prevalence of 32% in dogs, with significantly higher rates in coastal and insular regions compared to the Andean highlands [11]. Similarly, a study in Southern Italy found that 39.2% of dog fecal samples tested positive for hookworm eggs [2]. High prevalence rates are often seen in shelter environments, with one study in the Balkans reporting that 88% of dogs were infected with at least one parasite, with hookworms being the most common [10]. These findings underscore the widespread nature of the problem and the constant risk of exposure for both dogs and humans. The role of free-roaming dogs is critical in environmental contamination. Research in the Northern Philippines identified *A. ceylanicum* as the predominant hookworm species in environmentally collected canine feces, highlighting the role of these dogs as reservoirs for zoonotic infection [7]. Even in protected areas, such as national parks in Ghana, dogs carry high burdens of intestinal parasites, including hookworms, creating a nexus for transmission between humans, non-human primates, and dogs [12]. Environmental contamination is not just a rural issue; a study in public areas of São Paulo State, Brazil, detected *Ancylostoma* spp. eggs in 12.5% of fecal samples collected from public squares, emphasizing the risk of CLM in urban settings [13]. ## Cutaneous Larva Migrans: The Zoonotic Consequence Cutaneous larva migrans (CLM) is a neglected tropical disease caused by zoonotic hookworm larvae, most commonly *A. braziliense* and *A. caninum* [3]. When the infective L3 larvae of these animal hookworms come into contact with human skin, they are unable to complete their life cycle and instead burrow through the epidermis, creating characteristic serpiginous (snake-like), intensely pruritic (itchy) tracks [3]. ### Clinical Presentation and Diagnosis in Humans The typical presentation of CLM is a red, winding, raised track that advances a few millimeters to a few centimeters per day, accompanied by severe itching [6][3]. The most common sites of infection are the feet and legs, often acquired by walking barefoot on contaminated beaches or soil [6][4]. A case report from Ecuador detailed a 24-year-old woman who developed a pruritic lesion on her foot nine days after walking barefoot on a wet, potentially contaminated beach [3]. The lesion was initially misdiagnosed as scabies and plantar warts, delaying proper care for 26 days [3]. This highlights a significant challenge: early-stage CLM can be difficult to recognize, even for healthcare professionals [3]. Diagnosis is primarily clinical, based on the patient's history of potential exposure and the characteristic appearance of the skin lesions [3]. Laboratory tests are generally not required. However, the diagnosis can be complicated by the fact that many cases occur without a clear history of international travel. A study within the US Military Health System found that 69.4% of confirmed CLM cases were diagnosed within the United States without documented preceding international travel, with 80% of these autochthonous (locally acquired) cases occurring in the South region [4]. The most common exposures were spending time on the beach, exposure to pet dogs, or walking barefoot outdoors [4]. ### Treatment and Management of CLM The mainstay of treatment for CLM is oral anthelmintic therapy. Single-dose oral ivermectin is the most commonly recommended treatment, but repeat doses are sometimes necessary [6]. Oral albendazole is another effective option, often given at 400 mg/day for a short course. In the case from Ecuador, treatment with albendazole (400 mg/day for 4 days) led to rapid symptomatic relief within three days, with complete resolution by day 50 [3]. However, there is growing concern regarding treatment failure. A case report from tropical Australia described a patient with CLM that was refractory to two doses of ivermectin [6]. This occurred in a context where companion animals and wildlife were exposed to antiparasitic agents, raising concerns about drug resistance. The infection was eventually cured with a combination regimen of multiple doses of albendazole and ivermectin [6]. The authors now recommend combination therapy with ivermectin and albendazole for relapsed CLM [6]. This case underscores the critical role of a One Health approach to surveillance and response for emerging drug resistance [6]. ## Anemia and Other Clinical Signs in Dogs While CLM is a significant human health concern, the direct impact of hookworms on dogs, particularly puppies, can be severe and life-threatening. The primary pathological effect is blood loss caused by the adult worms attaching to the intestinal wall and feeding on blood. This can lead to anemia, which is a reduction in the number of red blood cells or hemoglobin. ### Pathophysiology of Hookworm Anemia Adult hookworms cause blood loss through two mechanisms: direct blood feeding and the secretion of anticoagulant compounds that cause continuous bleeding from the attachment site. The severity of anemia depends on the intensity of the infection and the age and overall health of the dog. In a confirmed case of *A. caninum* infection in a 15-month-old dog in the Slovak Republic, the dog presented with severe, persistent diarrhoea, and haematological examination revealed a decrease in erythrocyte and haemoglobin levels, as well as mild eosinophilia [1]. This case highlights the direct link between hookworm infection and anemia. ### Clinical Signs in Puppies and Adult Dogs Puppies are particularly vulnerable to the effects of hookworm anemia. Common clinical signs associated with acute infections include: - **Anemia:** Pale or white gums and mucous membranes, weakness, lethargy [1][5]. - **Gastrointestinal Signs:** Melena (dark, tarry, digested blood in the stool), hematochezia (fresh blood in the stool), diarrhea, and dehydration [1][5]. - **Poor Growth:** Poor weight gain or weight loss, failure to thrive [5]. - **Other Signs:** Dull hair coat, poor body condition. In adult dogs, chronic infections may be more subtle, manifesting as weight loss, poor appetite, and a dull coat. However, acute, severe blood loss can also occur in adult dogs, especially in cases of massive infection. ### Diagnosis in Dogs The diagnosis of hookworm infection in dogs is typically made by identifying hookworm eggs in a fecal sample using a technique called fecal flotation [7][5]. However, microscopic examination cannot differentiate between the eggs of different hookworm species [7]. For species identification, which is becoming increasingly important due to drug resistance, molecular techniques such as PCR and Sanger sequencing are required [7][2]. Accurate species identification is essential, as some species, like *U. stenocephala*, may have different susceptibilities to certain anthelmintics [2]. ## The Growing Threat: Anthelmintic Drug Resistance The management of hookworm infections has been complicated by the emergence and spread of anthelmintic drug resistance, particularly in *A. caninum*. This is now considered a matter of urgent concern for veterinarians in North America and elsewhere [5]. ### Multiple Anthelmintic Drug Resistance (MADR) Cases of *A. caninum* resistant to all anthelmintic classes registered in the USA for control of this parasite were first reported in 2019 [8]. This phenomenon, termed Multiple Anthelmintic Drug Resistance (MADR), has subsequently been reported in pet dogs across the USA [8]. The American Association of Veterinary Parasitologists (AAVP) established a Hookworm Task Force in 2021 to address this issue [5]. The task force's review confirms that multiple anthelmintic drug resistance to fenbendazole, moxidectin, and pyrantel pamoate is now documented in *A. caninum* in the US [5]. Clinical and genetic evidence strongly suggests that MADR likely originated on Greyhound breeding farms and kennels, but the problem is no longer restricted to this breed [5][8]. Recent studies have shown that drug-resistant *A. caninum* is present in dogs of all sizes, ages, and breeds and at varying but always high prevalence in every region of the continental US [5]. ### Mechanisms of Resistance The molecular mechanisms underlying anthelmintic resistance are complex. One well-characterized mechanism for benzimidazole (BZ) resistance involves mutations in the β-tubulin gene, such as the F167Y mutation [14]. Recent research has revealed a previously uncharacterized association between resistance to macrocyclic lactones (MLs) and benzimidazoles in *A. caninum* [14]. In one study, serial passaging of a wild-type isolate without treatment led to an unexpected rise in the F167Y allele frequency, accompanied by increased resistance to ivermectin (an ML) but not to thiabendazole (a BZ) [14]. This suggests that ML resistance may be associated with canonical BZ resistance mutations, and that the F167Y mutation may not confer any negative fitness effects; instead, it correlated with increased egg output and prolonged infection [14]. This finding has significant implications for understanding the spread of resistance. ### Diagnosis and Management of Resistant Hookworms The AAVP Hookworm Task Force has provided guidance on best practices for the diagnosis, treatment, and management of drug-resistant hookworms [5]. This includes performing fecal egg count reduction tests (FECRT) to confirm treatment efficacy and using combination therapy or alternative drug classes when resistance is suspected [5]. The task force also emphasizes the need for research into new anthelmintic targets and the development of better diagnostic tools [8]. For veterinarians, this means moving away from routine, blanket deworming protocols and towards a more strategic, evidence-based approach. ## Evidence-Based Treatment and Prevention Effective management of hookworms in dogs requires a multi-faceted approach that includes treating infected animals, implementing preventive measures, and addressing environmental contamination. ### Treatment Protocols Several anthelmintic drugs are effective against hookworms, including pyrantel pamoate, fenbendazole, moxidectin, and milbemycin oxime. However, given the rise of resistance, treatment should be tailored to the individual patient and ideally guided by diagnostic testing. - **Standard Dewormers:** Products containing pyrantel pamoate and moxidectin, such as the combination formulation of fluralaner, moxidectin, and pyrantel (BRAVECTO TriUNO), have been shown to be highly effective against canine intestinal nematode infections, including hookworms [15][16]. A field study demonstrated that this combination was effective in treating dogs with positive pre-treatment fecal egg counts [15]. Similarly, a non-terminal dose confirmation study confirmed its efficacy against adult hookworms (*U. stenocephala* and *A. caninum*) [16]. - **Addressing Resistance:** In cases of suspected or confirmed drug resistance, treatment protocols must be adjusted. This may involve using higher doses, switching to a different drug class, or using a combination of drugs. The AAVP task force recommends a [fecal egg count reduction test](/knowledge/diagnostics/parasitology/fecal-egg-count-reduction-test-for-anthelmintic-resistance) to monitor treatment efficacy [5]. For dogs with MADR hookworms, a multi-drug approach is often necessary, though options may be limited [8]. ### Prevention and Environmental Control Prevention is the cornerstone of hookworm control. Key strategies include: - **Regular Deworming:** All dogs, especially puppies, should be on a regular deworming schedule as recommended by a veterinarian. The American Animal Hospital Association (AAHA) and the Companion Animal Parasite Council (CAPC) provide guidelines that emphasize year-round prevention, but these should be adapted to local risk and the individual dog's lifestyle. - **Prompt Feces Removal:** Immediate and proper disposal of dog feces from yards, parks, and public areas is critical to prevent environmental contamination [13]. - **Hygiene and Sanitation:** In public areas, particularly beaches and parks, measures to prevent dog defecation in high-traffic zones can reduce the risk of human exposure to larvae [13]. - **One Health Approach:** The control of hookworms requires a collaborative effort between veterinarians, physicians, and public health officials. This is particularly important in the face of emerging drug resistance [6]. Education of pet owners and the community about the risks of zoonotic parasites is essential [13]. ## Regional Considerations for Management The approach to hookworm control may vary by region due to differences in parasite species, climate, and local guidelines. - **North America (US and Canada):** The primary concern is the high prevalence of drug-resistant *A. caninum* [5][8]. The AAVP task force provides specific guidance for US veterinarians [5]. In Canada, the prevalence of resistant hookworms is also being reported [8]. - **Europe:** In Central Europe, *A. caninum* has been historically rare, but a confirmed case in Slovakia suggests a potential northward expansion, possibly due to climate change [1]. In Southern Europe, both *A. caninum* and *U. stenocephala* are prevalent, and accurate species diagnosis is crucial because *U. stenocephala* may be less susceptible to some drugs like milbemycin oxime [2]. In the Balkans, *U. stenocephala* is the major hookworm species in shelter dogs [10]. - **Australia:** In tropical Australia, there is concern about the emergence of anthelmintic resistance in hookworms, as highlighted by the case of refractory CLM [6]. The Australian Veterinary Association (AVA) and the Department of Agriculture, Fisheries and Forestry (DAFF) emphasize responsible antiparasitic use. - **Asia and South America:** These regions often have a high prevalence of hookworms, including the zoonotic *A. ceylanicum* [7][17]. A study in the Northern Mariana Islands found a high prevalence of GI parasites, including *A. ceylanicum* [17]. In India, *A. braziliense* has been molecularly confirmed in dogs, adding to the complexity of the epidemiological picture [18]. ## Limitations and When to Contact a Veterinarian This article provides a comprehensive overview of hookworms in dogs, but it has limitations. It cannot predict the specific risk of hookworm infection for an individual dog, as this depends on a complex interplay of factors including geographic location, lifestyle, age, and the presence of other health conditions. It also cannot provide breed-level information, as susceptibility to hookworm infection is not typically breed-specific, but the clinical impact can vary based on a dog's size and overall health. You should contact your veterinarian immediately if you observe any of the following in your dog: - Pale or white gums, which can indicate significant blood loss. - Dark, tarry, or bloody stools. - Vomiting or diarrhea, especially in a puppy. - Lethargy, weakness, or collapse. - Poor appetite or weight loss. - In puppies, any signs of failure to thrive or poor growth. These are potential signs of a severe hookworm infection or other serious underlying disease. Prompt veterinary intervention can be life-saving. ## Frequently Asked Questions ### What are the first signs of hookworms in a puppy? The first signs of hookworms in a puppy often include pale gums, weakness, lethargy, and dark, tarry stools (melena), which are direct consequences of blood loss from the intestinal attachment of adult worms [1][5]. ### How do dogs get hookworms? Dogs can get hookworms by ingesting infective larvae from a contaminated environment, by larvae penetrating their skin, or, in the case of puppies, through the mother's milk (transmammary transmission) [1][3]. ### Can I get hookworms from my dog? Yes, hookworms are zoonotic. The most common human infection is cutaneous larva migrans (CLM), where the larvae penetrate the skin, causing itchy, winding tracks [3]. In rare cases, *A. caninum* can cause intestinal infection in humans [9]. ### How is hookworm infection in dogs diagnosed? Hookworm infection is typically diagnosed by identifying hookworm eggs in a fecal sample using a microscope (fecal flotation) [7][5]. Molecular tests like PCR are used for species identification, which is important for guiding treatment, especially with the emergence of drug resistance [7][2]. ### What is the best treatment for hookworms in dogs? The best treatment depends on the specific situation. Standard dewormers like pyrantel pamoate and moxidectin are often effective [15][16]. However, due to the rise of drug-resistant hookworms, your veterinarian may recommend a fecal egg count reduction test and adjust the treatment protocol accordingly [5]. ### Are hookworms becoming resistant to deworming medications? Yes, multiple anthelmintic drug resistance (MADR) in *Ancylostoma caninum* is a growing and urgent concern, particularly in the United States [5][8]. This means that some hookworm strains are resistant to all common deworming drug classes [8]. ### How can I prevent my dog from getting hookworms? Prevention involves regular veterinary-recommended deworming, prompt removal and disposal of your dog's feces from your yard and public spaces, and maintaining good hygiene [13]. A One Health approach that includes community education is also vital [6][13]. ### What should I do if I think I have cutaneous larva migrans? You should see a doctor or dermatologist for diagnosis and treatment. CLM is treatable with oral medications like albendazole or ivermectin [6][3]. Do not attempt to treat it with over-the-counter remedies, as this can delay proper care [3].